SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-183364
Filing Date
2020-06-30
Accepted
2020-06-30 08:06:31
Documents
12
Period of Report
2020-06-30
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d948294d8k.htm   iXBRL 8-K 37577
  Complete submission text file 0001193125-20-183364.txt   164266

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA onct-20200630.xsd EX-101.SCH 3073
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE onct-20200630_lab.xml EX-101.LAB 18139
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE onct-20200630_pre.xml EX-101.PRE 11410
5 EXTRACTED XBRL INSTANCE DOCUMENT d948294d8k_htm.xml XML 3414
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50549 | Film No.: 201000473
SIC: 2834 Pharmaceutical Preparations